News & AnalysisProciseDx snags $10.5m Series AProciseDx Inc, an vitro diagnostics company, has raised $10.5 million in Series A funding.ByIris Dorbian21 July 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs